Canopy Growth (Canopy Growth) Debt-to-Equity

: 1.27 (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

Canopy Growth's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $78.5 Mil. Canopy Growth's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $438.2 Mil. Canopy Growth's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $405.9 Mil. Canopy Growth's debt to equity for the quarter that ended in Dec. 2023 was 1.27.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Canopy Growth's Debt-to-Equity or its related term are showing as below:

CGC' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01 Med: 0.13 Max: 1.87
Current: 1.27

During the past 13 years, the highest Debt-to-Equity Ratio of Canopy Growth was 1.87. The lowest was 0.01. And the median was 0.13.

CGC's Debt-to-Equity is ranked worse than
90.62% of 853 companies
in the Drug Manufacturers industry
Industry Median: 0.29 vs CGC: 1.27

Canopy Growth Debt-to-Equity Historical Data

The historical data trend for Canopy Growth's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Canopy Growth Annual Data

Trend

Jul13

Dec14

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Debt-to-Equity

0.14

0.13

0.49

0.46

1.87

Canopy Growth Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity																0.93	1.87	1.34	1.02	1.27

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Canopy Growth's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Canopy Growth Debt-to-Equity Distribution

For the Drug Manufacturers industry and Healthcare sector, Canopy Growth's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Canopy Growth's Debt-to-Equity falls into.

Canopy Growth Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Canopy Growth's Debt to Equity Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(427.957	+	607.042)	/	554.29
	=	1.87

Canopy Growth's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(78.53	+	438.219)	/	405.877
	=	1.27

Canopy Growth (NAS:CGC) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Canopy Growth Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Canopy Growth's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Canopy Growth (Canopy Growth) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Canopy Growth Corp (NAS:CGC) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

11L:Germany WEED:Canada

Address

1 Hershey Drive, Smiths Falls, ON, CAN, K7A 0A8

Website

https://www.canopygrowth.com

Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include sports drink BioSteel, skincare products under This Works, Martha Stewart CBD, and Storz & Bickel vaporizers. Canopy growth is attempting to merge its U.S. assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.

Executives

Theresa Yanofsky	director	1 HERSHEY DRIVE, SMITHS FALLS A6 K7A 0A8
David Angelo Lazzarato	director	1 HERSHEY DRIVE, SMITHS FALLS A6 K7A 0A8
Judy Schmeling	director	C/O HSN, INC., 1 HSN DRIVE, ST.PETERSBURG FL 33729
Hong Judy Eun Joo	officer: See Remarks	1 HERSHEY DRIVE, SMITHS FALLS Z4 K7A 0A8
David Eric Klein	director, officer: Chief Executive Officer	207 HIGH POINT DRIVE, VICTOR NY 14564
Thomas Carlton Stewart	officer: See Remarks	1 HERSHEY DRIVE, SMITHS FALLS A6 K7A 0A8
Christelle Gedeon	officer: See Remarks	3 HOLLYHOCK COURT, TORONTO Z4 M3B 0B4
Garth Hankinson	director	C/O CONSTELLATION BRANDS, INC., 207 HIGH POINT DRIVE, BLDG. 100, VICTOR NY 14564
Greenstar Ii Holdings Llc	10 percent owner	207 HIGH POINT DRIVE, BUILDING 100, VICTOR NY 14564
Greenstar Ii Llc	10 percent owner	207 HIGH POINT DRIVE, BUILDING 100, VICTOR NY 14564
Rade Nikola Kovacevic	officer: President	1 HERSHEY DRIVE, SMITHS FALLS A6 K7A 0A8
Phillip Stephen Shaer	officer: Chief Legal Officer	1 HERSHEY DRIVE, SMITHS FALLS A6 K7A 0A8
Grant Julious C. Jr	officer: Chief Commercial Officer	1 HERSHEY DRIVE, SMITHS FALLS A6 K7A 0A8
Sabia James A. Jr.	director	C/O CONSTELLATION BRANDS, INC., 207 HIGH POINT DRIVE, BLDG. 100, VICTOR NY 14564
Tomas Iv Shipley	officer: See Remarks	1 HERSHEY DRIVE, SMITHS FALLS A6 K7A 0A8